Oruka Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Other Operating Liabilities of -$432.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2014-11-12
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2014-09-30 was $32.00K, a 18.52% increase year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2014-06-30 was $1.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2014-03-31 was -$465.00K, a 628.41% decline year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2013-12-31 was $583.00K, a 619.75% increase year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2013 was $681.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2012 was -$237.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2011 was -$220.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2010 was -$316.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 114 month | Increase (Decrease) in Other Operating Liabilities 117 month | Increase (Decrease) in Other Operating Liabilities 120 month | Increase (Decrease) in Other Operating Liabilities 123 month | Increase (Decrease) in Other Operating Liabilities 126 month | Increase (Decrease) in Other Operating Liabilities 129 month | Increase (Decrease) in Other Operating Liabilities 132 month | Increase (Decrease) in Other Operating Liabilities 135 month | Increase (Decrease) in Other Operating Liabilities 138 month | Increase (Decrease) in Other Operating Liabilities 141 month | Increase (Decrease) in Other Operating Liabilities 144 month | Increase (Decrease) in Other Operating Liabilities 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $33.00K derived: sum of 2 quarters · filed 2014-11-12 | -$432.00K 10-Q · filed 2014-11-12 | $151.00K derived: sum of 4 quarters · filed 2014-11-12 | ||||||||||||
| 2014-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$464.00K 10-Q · filed 2014-08-13 | $119.00K derived: sum of 3 quarters · filed 2014-08-13 | $146.00K derived: sum of 4 quarters · filed 2014-11-12 | ||||||||||||
| 2014-03-31 | -$465.00K 10-Q · filed 2014-05-13 | $118.00K derived: sum of 2 quarters · filed 2014-05-13 | $145.00K derived: sum of 3 quarters · filed 2014-11-12 | $128.00K derived: sum of 4 quarters · filed 2014-11-12 | -$19.00M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $610.00K derived: sum of 2 quarters · filed 2014-11-12 | $593.00K derived: sum of 3 quarters · filed 2014-11-12 | $681.00K 10-K · filed 2014-03-20 | -$18.54M 10-K · filed 2014-03-20 | |||||||||||
| 2013-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $10.00K derived: sum of 2 quarters · filed 2014-11-12 | $98.00K 10-Q · filed 2014-11-12 | $179.00K derived: sum of 4 quarters · filed 2014-11-12 | -$19.12M 10-Q · filed 2013-11-13 | |||||||||||
| 2013-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $71.00K 10-Q · filed 2014-08-13 | $152.00K derived: sum of 3 quarters · filed 2014-08-13 | $91.00K derived: sum of 4 quarters · filed 2014-08-13 | -$19.15M 10-Q · filed 2013-08-13 | |||||||||||
| 2013-03-31 | $88.00K 10-Q · filed 2014-05-13 | $169.00K derived: sum of 2 quarters · filed 2014-05-13 | $108.00K derived: sum of 3 quarters · filed 2014-05-13 | $11.00K derived: sum of 4 quarters · filed 2014-05-13 | -$19.13M 10-Q · filed 2013-05-13 | |||||||||||
| 2012-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $20.00K derived: sum of 2 quarters · filed 2014-03-20 | -$77.00K derived: sum of 3 quarters · filed 2014-03-20 | -$237.00K 10-K · filed 2014-03-20 | -$19.22M 10-K · filed 2013-03-21 | |||||||||||
| 2012-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$158.00K derived: sum of 2 quarters · filed 2013-11-13 | -$318.00K 10-Q · filed 2013-11-13 | -$154.00K derived: sum of 4 quarters · filed 2013-11-13 | -$19.30M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$257.00K 10-Q · filed 2013-08-13 | -$93.00K derived: sum of 3 quarters · filed 2013-08-13 | -$152.00K derived: sum of 4 quarters · filed 2013-08-13 | -$19.24M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$160.00K 10-Q · filed 2013-05-13 | $4.00K derived: sum of 2 quarters · filed 2013-05-13 | -$55.00K derived: sum of 3 quarters · filed 2013-05-13 | -$257.00K derived: sum of 4 quarters · filed 2013-05-13 | -$19.14M 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $105.00K derived: sum of 2 quarters · filed 2013-03-21 | -$97.00K derived: sum of 3 quarters · filed 2013-03-21 | -$220.00K 10-K · filed 2013-03-21 | -$18.98M 10-K · filed 2012-03-27 | |||||||||||
| 2011-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$261.00K derived: sum of 2 quarters · filed 2012-11-13 | -$384.00K 10-Q · filed 2012-11-13 | -$94.00K derived: sum of 4 quarters · filed 2012-11-13 | -$19.15M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | -$202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$325.00K 10-Q · filed 2012-08-13 | -$35.00K derived: sum of 3 quarters · filed 2012-08-13 | -$120.00K derived: sum of 4 quarters · filed 2012-08-13 | -$19.09M 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | -$123.00K 10-Q · filed 2012-05-14 | $167.00K derived: sum of 2 quarters · filed 2012-05-14 | $82.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||||||||||
| 2010-12-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $205.00K derived: sum of 2 quarters · filed 2012-03-27 | -$316.00K 10-K · filed 2012-03-27 | |||||||||||||
| 2010-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$606.00K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | -$521.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |